Dehydroascorbate (DHA), an oxidant, is formed from ascorbic acid during the removal of ROS, yet the enzyme responsible for converting DHA back to ascorbic acid is dependent on GSH
Consistent with the toxicity of isoniazid in slow acetylators, there is an increased incidence of other drug toxicities in subjects carrying defective alleles, such as lupus erythematosus in patients treated with hydralazine or procainamide (Sim et al., 1988), and haemolytic anemia and inflammatory bowel disease after treatment with sulfasalazine (Chen et al., 2007)
Preclinical research (animal studies) is extensive, with over 35 published studies showing benefits for tendon, ligament, muscle, and gut healing
Repair pathways reactivate
Our formulas are administered by medical professionals with the appropriate training and proven experience in IV therapy
The modeled spectral range was from 0.2 to 4.2 ppm